RxDoctor Payments Data

Carmen Escaba

Family · Haymarket, VANPI 1932872959

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,530 of the $2,430 with a category attached, or 63.0%. 20 manufacturers reported payments, led by Biohaven Pharmaceuticals, Inc. at 36.5% of the total. Reporting peaked in 2021 at $1,270 and has fallen 74.4% since, to $325 in 2023.

$2,430in general payments, 2019–2025

Across 80 payments — averaging $30.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Biohaven Pharmaceuticals, Inc.$886
  • AbbVie$299
  • Novartis$198
  • Intra-sana Laboratories$159
  • Redhill Biopharma Inc.$135
  • Novo Nordisk$128
  • plus $626 from 14 others

What the payments were for

  • Consulting fees$80033%
  • Food & beverage$1,53063%
  • Education$1004%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,430 in reported general payments places this provider in the 85th percentile of 4,332 family providers in Virginia.

See all family providers in Virginia →

Other family in Haymarket

See the full list for Virginia →

Where these figures come from

Is this you, or does something look wrong? →